Dimed Distribuidora de Medicamentos (BSP:PNVL3) Other Current Liabilities: R$154 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:PNVL3 Dimed SA Distribuidora de Medicamentos BSP:PNVL3
89 GF Score
Price R$11.26
GF Value R$13.72
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Dimed Distribuidora de Medicamentos Other Current Liabilities?

Dimed Distribuidora de Medicamentos BSP:PNVL3 +0.18% 89 Other Current Liabilities is R$154 Mil as of Mar. 2026. GuruFocus rates BSP:PNVL3 with a GF Score™ of 89/100 and a GF Value™ of R$13.72 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Dimed Distribuidora de Medicamentos's other current liabilities for the quarter that ended in Mar. 2026 was R$154 Mil.

Dimed Distribuidora de Medicamentos's quarterly other current liabilities declined from Sep. 2025 (R$185 Mil) to Dec. 2025 (R$165 Mil) and declined from Dec. 2025 (R$165 Mil) to Mar. 2026 (R$154 Mil).

Dimed Distribuidora de Medicamentos's annual other current liabilities increased from Dec. 2023 (R$138 Mil) to Dec. 2024 (R$182 Mil) but then declined from Dec. 2024 (R$182 Mil) to Dec. 2025 (R$165 Mil).

Dimed Distribuidora de Medicamentos Other Current Liabilities Related Terms

Dimed Distribuidora de Medicamentos Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Dimed Distribuidora de Medicamentos's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dimed Distribuidora de Medicamentos Other Current Liabilities Chart

Dimed Distribuidora de Medicamentos Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 51.17 129.31 137.80 182.37 164.67

Dimed Distribuidora de Medicamentos Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 161.46 180.98 184.80 164.67 153.97
BSP:PNVL3
89GF Score
Dimed SA Distribuidora de Medicamentos BSP:PNVL3
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dimed Distribuidora de Medicamentos Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of R$154 Mil mean?
Dimed Distribuidora de Medicamentos (BSP:PNVL3) has a Other Current Liabilities of R$154 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Dimed Distribuidora de Medicamentos.
Is Dimed Distribuidora de Medicamentos' Other Current Liabilities too high?
Dimed Distribuidora de Medicamentos' current Other Current Liabilities is R$154 Mil. Overall, Dimed Distribuidora de Medicamentos has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dimed Distribuidora de Medicamentos' Other Current Liabilities compare to LLY and JNJ?
Dimed Distribuidora de Medicamentos' Other Current Liabilities of R$154 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Drug Manufacturers company?
A good Other Current Liabilities depends on the Drug Manufacturers industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Dimed Distribuidora de Medicamentos. Dimed Distribuidora de Medicamentos's current Other Current Liabilities is R$154 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dimed Distribuidora de Medicamentos stock overvalued right now?
Based on GuruFocus' analysis, Dimed Distribuidora de Medicamentos (BSP:PNVL3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$13.72, compared to a current price of R$11.26 — trading 17.9% below its estimated fair value. The current Other Current Liabilities is R$154 Mil. Dimed Distribuidora de Medicamentos' overall GF Score™ is 89/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Dimed Distribuidora de Medicamentos (BSP:PNVL3), the current Other Current Liabilities is R$154 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dimed Distribuidora de Medicamentos (BSP:PNVL3) Overvalued in 2026?

Based on GuruFocus' analysis, Dimed Distribuidora de Medicamentos stock appears to be undervalued. The current stock price of R$11.26 is trading 17.9% below its estimated GF Value™ of R$13.72. GuruFocus considers Dimed Distribuidora de Medicamentos to be Modestly Undervalued.

Key valuation signals for BSP:PNVL3:

  • Other Current Liabilities: R$154 Mil
  • GF Value™: R$13.72 vs. price of R$11.26 (17.9% below fair value)
  • GF Score™: 89/100 with 5 warning signs

No single metric tells the full story. See the BSP:PNVL3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dimed Distribuidora de Medicamentos Business Description

Address Avenida Industrial Belgraf, 865, Eldorado do Sul, RS, BRA, 92990-000
Dimed SA Distribuidora de Medicamentos is engaged in the sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics. It has single reportable segment that is, The Retail segment. The Retail segment has 556 stores that sell more than 15,000 items among drugs and personal care and beauty products. In addition to adding divisions of cosmetics, drugs and food, Lifar is responsible for the production of brands in Brazil, as well as products of its own brand Panvel.
89GF Score

Get the complete analysis for BSP:PNVL3

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$11.26
Price
R$13.72
GF Value